DISSEMINATED SUPERFICIAL ACTINIC POROKERATOSIS

DISSEMINATED SUPERFICIAL ACTINIC POROKERATOSIS was reported 12 times

DISSEMINATED SUPERFICIAL ACTINIC POROKERATOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Thymic Stromal Lymphopoietin Blocker [EPC] 1 0.0001
1 Tissue-nonspecific Alkaline Phosphatase [EPC] 1 0.0001
2 PCSK9 Inhibitor [EPC] 1 0.0000
3 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
4 Microtubule Inhibitor [EPC] 2 0.0000
5 Interleukin-23 Antagonist [EPC] 1 0.0000
6 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
7 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
8 Janus Kinase Inhibitor [EPC] 1 0.0000
9 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
10 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
11 Corticosteroid [EPC] 2 0.0000